ArticleJournal of thoracic disease2026

Reply to the editor: patient selection and multimodality therapy in stage IV esophageal adenocarcinoma.

Marisa Sewell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.